phosphorus-radioisotopes and Hepatitis

phosphorus-radioisotopes has been researched along with Hepatitis* in 1 studies

Other Studies

1 other study(ies) available for phosphorus-radioisotopes and Hepatitis

Article	Year
[The side effect and complication of intraarterial phosphorus-32 glass microspheres for patients with advanced hepatoma]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 1997, Volume: 14, Issue:4 The phosphorus-32 glass microspheres(32P-GMS) is a new radioembolizer for cancer therapy. From March 1994 to April 1995, 24 patients with unresectable hepatocellular carcinoma and 3 patients with cavernous hemangioma received internal radiation treatment of 32P-GMS. The clinical results demonstrated that hepatic arterial instillation of 32P-GMS appeared to be safe and effective for hepatocellular carcinoma. There was no significant bone marrow or renal toxicity or liver to pulmonary bypass. A transient change of liver function and fever occurred in almost all patients. Significant liver toxicity and gastrointestinal tract reaction were seen when radiation dose > 50 Gy or microspheres > 3 g, and then various postoperative complications occurred. Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fever; Glass; Hemangioma, Cavernous; Hepatitis; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Phosphorus Radioisotopes; Radiation Dosage	1997

Article

Year

[The side effect and complication of intraarterial phosphorus-32 glass microspheres for patients with advanced hepatoma].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 1997, Volume: 14, Issue:4

The phosphorus-32 glass microspheres(32P-GMS) is a new radioembolizer for cancer therapy. From March 1994 to April 1995, 24 patients with unresectable hepatocellular carcinoma and 3 patients with cavernous hemangioma received internal radiation treatment of 32P-GMS. The clinical results demonstrated that hepatic arterial instillation of 32P-GMS appeared to be safe and effective for hepatocellular carcinoma. There was no significant bone marrow or renal toxicity or liver to pulmonary bypass. A transient change of liver function and fever occurred in almost all patients. Significant liver toxicity and gastrointestinal tract reaction were seen when radiation dose > 50 Gy or microspheres > 3 g, and then various postoperative complications occurred.

Topics: Adult; Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fever; Glass; Hemangioma, Cavernous; Hepatitis; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Phosphorus Radioisotopes; Radiation Dosage

1997